Johnson & Johnson Stock News

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 15th to review third-quarter results. Joaquin Duato, Chairman and Chief Executive Officer, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call. The q...

Johnson & Johnson (NYSE:JNJ ) Wells Fargo 2024 Healthcare Conference September 5, 2024 11:00 AM ET Company Participants Tim Schmid - Executive Vice President, Worldwide Chairman of MedTech Jessica Moore - Vice President of Investor Relations Tracy Menkowski - Senior Director of Investor Relations Conference Call Participants Larry Biegelsen - Wells Fargo Larry Biegelsen Barry, we're ready? All ...

SANTA CLARA, CA / ACCESSWIRE / September 5, 2024 / MEDevice Silicon Valley, the premier West Coast show connecting medical device engineers and cutting-edge medtech companies, returns to the Santa Clara Convention Center Nov. 20-21. Announced today, MEDevice Silicon Valley's lineup of keynote speakers will cover artificially intelligent (AI) and augmented reality (AR) driven Human Machine Inter...

If you're just a bit more worried about a market sell-off going into the fourth quarter, you're not alone.

24/7 Wall St. Insights Social Security is not enough to provide for a comfortable retirement.

Dividend cuts and suspensions can come suddenly and investors should always be on the lookout for warning signs. A strong track record for dividend growth is by no means a guarantee that a company will pay and increase its dividend in the future.

Johnson & Johnson is expected to secure more votes in favor of its talc settlement plan after increasing its offer to claimants, which has swayed a longtime legal adversary, WSJ reported on Wednesday, citing people familiar with the matter.

Johnson & Johnson (NYSE:JNJ ) Morgan Stanley 22nd Annual Global Healthcare Conference September 4, 2024 10:45 AM ET Company Participants Joaquin Duato - CEO & Chairman John Reed - Head of Pharma R&D Conference Call Participants Terence Flynn - Morgan Stanley Terence Flynn Great. All right.